LINC-ROR and neoplasm: Experimental studies on mice bearing melanoma tumors have indicated that ROR agonist-primed cells possess a stem-like memory phenotype and provide long-term protection against tumor challenge when co-infused with TRP-1 Th17 and pmel-1 Tc17.